Linoleic Acid Amide

CAS No. 3999-01-7

Linoleic Acid Amide( Linoleamide | 9,12-Octadecadienamide )

Catalog No. M28094 CAS No. 3999-01-7

Linoleic acid amide is a primary fatty acid amide derived from linoleic acid . It is reported to regulate Ca2+ flux by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (IC50 = 15-53 µM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 Get Quote
10MG 64 Get Quote
25MG 156 Get Quote
50MG 278 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Linoleic Acid Amide
  • Note
    Research use only, not for human use.
  • Brief Description
    Linoleic acid amide is a primary fatty acid amide derived from linoleic acid . It is reported to regulate Ca2+ flux by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (IC50 = 15-53 µM).
  • Description
    Linoleic acid amide is a primary fatty acid amide derived from linoleic acid . It is reported to regulate Ca2+ flux by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (IC50 = 15-53 µM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Linoleamide | 9,12-Octadecadienamide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    P2Y12
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3999-01-7
  • Formula Weight
    279.468
  • Molecular Formula
    C18H33NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCC\C=C/C\C=C/CCCCCCCC(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Angiolillo DJ, et al. Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudyfrom the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circ Cardiovasc Interv. 2012 Jun;5(3):347-56.
molnova catalog
related products
  • T3Inh-1

    T3Inh-1 is an effective and selective inhibitor of ppGalNAc-T3 with an IC50 of 7 μM. T3Inh-1 prevents breast cancer cells. T3Inh-1 reduces FGF23 hormone levels in both tissue cells and mice, without causing any toxic side effects.

  • DEPC

    DEPC (Diethyl pyrocarbonate) is a potent and irreversible RNase inhibitor containing histidine residues.DEPC can be used to prevent RNA enzyme degradation by modifying histidine residues with carboxylation resulting in enzyme inactivation.

  • AGN-190299

    AGN-190299 is a retinoid prodrug which is converted to its active form.